Skip to main content
Fig. 5 | BMC Complementary Medicine and Therapies

Fig. 5

From: Inhibition of IL-17 signaling in macrophages underlies the anti-arthritic effects of halofuginone hydrobromide: Network pharmacology, molecular docking, and experimental validation

Fig. 5

Binding energies of HF and core targets (kcal/mol). (A) The binding energy results of molecular docking. (B) Docking pattern of HF with MMP9. (C) Docking pattern of HF with EGFR. (D) Docking pattern of HF with ESR1. (E) Docking pattern of HF with MAPK1. (F) Docking pattern of HF with JAK2. (G) Docking pattern of HF with MMP2. (H) Docking pattern of HF with PPARG. (I) Docking pattern of HF with MAPK8. (J) Docking pattern of HF with TLR4. (K) Docking pattern of HF with STAT1.

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us